Concepedia

Stanislas Blein

SB

11

Publications

312

Citations

11

H-Index

2004

Active since

Affiliations

Glenmark Pharmaceuticals (Switzerland)(Current)

Ichnos Sciences (United States)

Glenmark Pharmaceuticals (India)

Nantes Université

Nuffield Orthopaedic Centre

Stanislas Blein is an author at Glenmark Pharmaceuticals (Switzerland) specializing in medicine, cell biology, and immunotherapy.

ORCID

Top concepts

Publications per year

2004–2024

11

Publications

11

Structural Analysis of the Complement Control Protein (CCP) Modules of GABAB Receptor 1a

Stanislas Blein, Rachel Ginham, Brian O. Smith et al. · Journal of Biological Chemistry · 2004 · 64 citations · Full text

Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies

Darko Skegro, Cian Stutz, Romain Ollier et al. · Journal of Biological Chemistry · 2017 · 46 citations · Full text

Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis

Barbara Rewerska, Lawrence Sher, Sady Alpizar et al. · Journal of Allergy and Clinical Immunology Global · 2023 · 39 citations · Full text

, , +9

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells

Laura Carretero-Iglesia, O. Hall, Jérémy Berret et al. · Nature Cancer · 2024 · 28 citations · Full text

, , +8

BEAT® the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGs

Pierre Moretti, Darko Skegro, Romain Ollier et al. · BMC Proceedings · 2013 · 27 citations · Full text

Rows per page

1–5 of 11